Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)

BACKGROUND: Selective cyclooxygenase-2 inhibitors and conventional non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs) have been associated with adverse cardiovascular (CV) effects. We compared the CV safety of switching to celecoxib vs. continuing nsNSAID therapy in a European setting. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Heart J
Main Authors: MacDonald, Thomas M., Hawkey, Chris J., Ford, Ian, McMurray, John J.V., Scheiman, James M., Hallas, Jesper, Findlay, Evelyn, Grobbee, Diederick E., Hobbs, F.D. Richard, Ralston, Stuart H., Reid, David M., Walters, Matthew R., Webster, John, Ruschitzka, Frank, Ritchie, Lewis D., Perez-Gutthann, Susana, Connolly, Eugene, Greenlaw, Nicola, Wilson, Adam, Wei, Li, Mackenzie, Isla S.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837371/
https://ncbi.nlm.nih.gov/pubmed/27705888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw387
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados